MIRM - Mirum Pharmaceuticals, Inc.

QQQ $ 589.90 $ -21.70 (-3.55 %)

DIA $ 460.24 $ -6.40 (-1.37 %)

SPY $ 656.81 $ -16.09 (-2.4 %)

TLT $ 89.21 $ 0.22 (0.24 %)

GLD $ 375.18 $ 0.00 (0 %)

Previous Close

$ 70.435

Open

$ 71.24

Bid

$ 70.33 x 270

Ask

$ 70.47 x 12

Day's Range

$ 69.49 - $ 71.48

52 Week Range

$ 36.88 - $ 78.54

Volume

591,044

Average Volume

Market Cap

3.62B

Beta (5Y Monthly)

$ 0.65

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-04-2025	09-30-2025	10-Q
2	08-06-2025	06-30-2025	10-Q
3	05-07-2025	03-31-2025	10-Q
4	02-26-2025	01-01-1970	10-K
5	11-12-2024	09-30-2024	10-Q
6	08-07-2024	06-30-2024	10-Q
7	05-08-2024	03-31-2024	10-Q
8	03-15-2024	12-31-2023	10-K
9	11-02-2023	09-30-2023	10-Q
10	08-07-2023	06-30-2023	10-Q
11	05-04-2023	03-31-2023	10-Q
12	03-08-2023	12-31-2022	10-K
13	11-09-2022	09-30-2022	10-Q
14	08-04-2022	06-30-2022	10-Q
15	05-05-2022	03-31-2022	10-Q
16	03-09-2022	12-31-2021	10-K
17	11-15-2021	09-30-2021	10-Q
18	08-05-2021	06-30-2021	10-Q
19	05-06-2021	03-31-2021	10-Q
20	03-09-2021	12-31-2020	10-K
21	11-12-2020	09-30-2020	10-Q
22	08-06-2020	06-30-2020	10-Q
23	05-07-2020	03-31-2020	10-Q
24	03-12-2020	12-31-2019	10-K
25	11-06-2019	09-30-2019	10-Q
26	08-28-2019	06-30-2019	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Mirum Pharmaceuticals Receives Paragraph I...
11/17/2025 21:57:31

On November 17, 2025, Mirum Pharmaceuticals, Inc. (the "Company") received a Paragraph IV Certification Notice Letter (...

Mirum Pharma To Share Multiple Presentatio...
11/07/2025 13:12:12

New data reinforce Mirum's commitment to advancing therapies and improving the lives of patients across diverse rare liver ...

Cantor Fitzgerald Maintains Overweight on ...
11/05/2025 16:08:04

Cantor Fitzgerald analyst Josh Schimmer maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Overweight and raises the price...

Citizens Maintains Market Outperform on Mi...
11/05/2025 13:01:43

Citizens analyst Jonathan Wolleben maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Market Outperform and raises the pri...

What Analysts Are Saying About Mirum Pharm...
11/05/2025 11:45:21

HC Wainwright & Co. Maintains Buy on Mirum...
11/05/2025 11:32:45

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Buy and raises t...

Mirum Pharmaceuticals Raises FY2025 Sales ...
11/04/2025 21:03:12

Mirum Pharmaceuticals (NASDAQ:MIRM) raises FY2025 sales outlook from $490.000 million-$510.000 million to $500.000 million-$510...

Mirum Pharmaceuticals Q3 EPS $0.05 Beats $...
11/04/2025 21:02:49

Mirum Pharmaceuticals (NASDAQ:MIRM) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of...

Earnings Scheduled For November 4, 2025
11/04/2025 11:12:08

8 Analysts Assess Mirum Pharmaceuticals: W...
10/16/2025 20:00:37

Morgan Stanley Maintains Overweight on Mir...
10/16/2025 18:00:33

Morgan Stanley analyst Michael Ulz maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Overweight and raises the price targ...

this-riot-platforms-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-wednesday

This Riot Platforms Analyst Begins Coverag...
09/24/2025 18:35:36

TD Cowen Initiates Coverage On Mirum Pharm...
09/24/2025 16:01:08

TD Cowen analyst Joseph Thome initiates coverage on Mirum Pharmaceuticals (NASDAQ:MIRM) with a Buy rating and announces Pric...

Demystifying Mirum Pharmaceuticals: Insigh...
09/12/2025 13:01:47

JP Morgan Maintains Overweight on Mirum Ph...
09/12/2025 11:16:31

JP Morgan analyst Jessica Fye maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Overweight and raises the price target fr...

Mirum Pharmaceuticals Completes Enrollment...
09/08/2025 12:08:48

Stifel Reinstates Buy on Mirum Pharmaceuti...
08/11/2025 11:11:37

Stifel analyst Dae Gon Ha reinstates Mirum Pharmaceuticals (NASDAQ:MIRM) with a Buy and announces $89 price target.

Deep Dive Into Mirum Pharmaceuticals Stock...
08/08/2025 18:02:12

Evercore ISI Group Maintains Outperform on...
08/08/2025 12:36:21

Evercore ISI Group analyst Gavin Clark-Gartner maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Outperform and raises th...

JMP Securities Maintains Market Outperform...
08/07/2025 13:36:12

JMP Securities analyst Jonathan Wolleben maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Market Outperform and raises t...